Effects of Labeling Patients as Prehypertensive

References

1. ↵
   Haynes RB, Sackett DL, Taylor DW, et al. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299: 741–4.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Polk BF, Harlan LC, Cooper SP, et al. Disability days associated with detection and treatment in a hypertension control program. Am J Epidemiol 1984; 119: 44–53.

   OpenUrlAbstract/FREE Full Text
3. ↵
   Alderman MH, Charlson ME, Melcher LA. Labelling and absenteeism: the Massachusetts Mutual Experience. Clin Invest Med 1981; 4: 165–71.

   OpenUrlPubMedWeb of Science
4. ↵
   Taylor DW, Haynes RB, Sackett DL, Gibson ES. Long-term follow-up of absenteeism among working men following the detection and treatment of their hypertension. Clin Invest Med 1981; 4: 173–7.

   OpenUrlPubMedWeb of Science
5. ↵
   Monk M. Blood pressure awareness and psychological well-being in the health and nutrition examination survey. Clin Invest Med 1981; 4: 183–9.

   OpenUrlPubMedWeb of Science
6. ↵
   Bloom JR, Monterossa S. Hypertension labeling and sense of well-being. Am J Pub Health 1981; 71: 1228–32.

   OpenUrlPubMedWeb of Science
7. ↵
   Barger SD, Muldoon MF. Hypertension labeling was associated with poorer self-rated health in the third US national health and nutrition examination survey. J Hum Hypertens 2006; 20: 117–23.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Francisco M, Martin-Escudero JC, Simal-Blanco F, et al. Health-related qualify of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens 2003; 21: 1283–9.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Mold JW, Hamm RM, Jafri B. The effect of labeling on perceived ability to recover from acute illnesses and injuries. J Fam Pract 2000; 49: 437–40.

   OpenUrlPubMedWeb of Science
10. ↵
    Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–72.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines. Arch Intern Med 2004; 164: 2126–34.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Svetkey LP. Management of prehypertension. Hypertension 2005; 45: 1056–61.

    OpenUrlFREE Full Text
13. ↵
    O’Brien E, Pickering T, Asmar R, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002; 7: 3–17.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160–4.

    OpenUrlAbstract/FREE Full Text
15. ↵
    National Heart Lung and Blood Institute. Your Guide to Lowering High Blood Pressure, NHLBI. Available at http://www.nhlbi.nih.gov/hbp/index.html. Accessed 29 July 2010.
16. ↵
    Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005.
17. ↵
    Zhao YD, Rahardja D, Qu Y. Sample size calculation for the Wilcoxon-Mann-Whitney test adjusting for ties. Stat Med 2008; 27: 462–8.

    OpenUrlCrossRefPubMed
18. ↵
    Nanna MJ, Sawilowsky SS. Analysis of Likert scale data in disability and medical rehabilitation research. Psychol Methods 1998; 3: 55–67.

    OpenUrl
19. ↵
    Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311: 1145–8.

    OpenUrlFREE Full Text
20. ↵
    Viera AJ. The “new” normal blood pressure: what are the implications for family medicine? J Am Board Fam Med 2007; 20: 45–51.

    OpenUrlAbstract/FREE Full Text
21. ↵
    Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002; 287: 1003–10.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882–8.

    OpenUrlCrossRefPubMedWeb of Science
23. Havas S, Dickinson BD, Wilson M. The urgent need to reduce sodium consumption. JAMA 2007; 298: 1439–41.

    OpenUrlCrossRefPubMed
24. Zaman MJ. Health protection requires legislation. BMJ 2007; 334: 967.

    OpenUrlFREE Full Text
25. Bibbins-Domingo K, Chertow GM, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362: 590–9.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Cherrington A, Corbie-Smith G, Pathman DE. Do adults who believe in periodic health examinations receive more clinical preventive services? Prev Med 2007; 45: 282–9.

    OpenUrlCrossRefPubMed